Sickle cell trait, hemoglobin c trait, and invasive pneumococcal disease

Epidemiology

Volumn 21, Issue 3, 2010, Pages 340-346

  Poehling, Katherine A ^a   Light, Laney S ^a   Rhodes, Melissa ^a   Snively, Beverly M ^a   Halasa, Natasha B ^a   Mitchel, Ed ^b   Schaffner, William ^b   Craig, Allen S ^c   Griffin, Marie R ^b,d  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c TENNESSEE DEPARTMENT OF HEALTH   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN C; PNEUMOCOCCUS VACCINE;

AFRICAN AMERICAN; ARTICLE; ASTHMA; BIRTH CERTIFICATE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; ETHNICITY; EUROPEAN AMERICAN; GENDER; HISPANIC; HUMAN; INFANT; NEWBORN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; UNITED STATES;

CHILD, PRESCHOOL; FEMALE; HEMOGLOBIN C; HUMANS; INFANT; INFANT, NEWBORN; MALE; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; RISK FACTORS; SICKLE CELL TRAIT; STREPTOCOCCUS PNEUMONIAE; TENNESSEE;

EID: 77950947551     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181d61af8     Document Type: Article

References (55)

1. Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA. 2006;295:1668-1674.
2. Flannery B, Schrag S, Bennett NM, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA. 2004;291:2197-2203.
3. Talbot TR, Poehling KA, Hartert TV, et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2004;39:641-648.
4. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297:1784-1792.
5. Moore MR, Gertz RE Jr, Woodbury RL, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis. 2008;197:1016-1027.
6. Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics. 2008;121:562-569.
7. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49:1-35.
8. Pearson HA. Prevention of pneumococcal disease in sickle cell anemia. J Pediatr. 1996;129:788-789.
9. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
10. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1428-1433.
11. Nowak-Wegrzyn A, Winkelstein JA, Swift AJ, Lederman HM. Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group. Clin Diagn Lab Immunol. 2000;7:788-793.
12. Fairhurst RM, Casella JF. Images in clinical medicine. Homozygous hemoglobin C disease. N Engl J Med. 2004;350:e24.
13. Schuchat A, Hilger T, Zell E, et al. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis. 2001;7:92-99.
14. U.S. Census. [U S Census Bureau]. Available at: www.factfinder.census. gov. Accessed August 31, 2009.
15. Mirvis DM, Chang CF, Hall CJ, Zaar GT, Applegate WB. TennCare-health system reform for Tennessee. JAMA. 1995;274:1235-1241
16. International Classification of Diseases. 6th ed, 9th rev. Clinical Modification: ICD-9-CM Professional for Hospitals. 6th ed. Salt Lake City, UT: Ingenix/St. Anthony Publishing; 2002.
17. Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352:2082-2090.
18. Lorey FW, Arnopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol. 1996;13:501-512.
19. Sears DA. The morbidity of sickle cell trait: a review of the literature. Am J Med. 1978;64:1021-1036.
20. Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA. 2001;285:1729-1735.
21. Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumococcal bacteremia in Charleston County, South Carolina. A decade later. Arch Intern Med. 1990;150:1401-1405.
22. Schlech WF III, Ward JI, Band JD, Hightower A, Fraser DW, Broome CV Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA. 1985;253:1749-1754.
23. Bradley JS, Kaplan SL, Tan TQ, et al. Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG). Pediatrics. 1998;102:1376-1382.
24. McCurdy PR. 32-DFP and 51-Cr for measurement of red cell life span in abnormal hemoglobin syndromes. Blood. 1969;33:214-224.
25. Prindle KH Jr, McCurdy PR. Red cell lifespan in hemoglobin C disorders (with special reference to hemoglobin C trait). Blood. 1970; 36:14-19.
26. Abu-Zeid YA, Theander TG, Abdulhadi NH, et al. Modulation of the cellular immune response during Plasmodium falciparum infections in sickle cell trait individuals. Clin Exp Immunol. 1992;88:112-118.
27. Ntoumi F, Mercereau-Puijalon O, Ossari S, et al. Plasmodium falciparum: sickle-cell trait is associated with higher prevalence of multiple infections in Gabonese children with asymptomatic infections. Exp Parasitol. 1997;87:39-46.
28. Le Hesran JY, Personne I, Personne P, et al. Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait. Int J Epidemiol. 1999;28:793-798.
29. Williams TN, Mwangi TW, Roberts DJ, et al. An immune basis for malaria protection by the sickle cell trait. PLoS Med. 2005;2:e128.
30. Verra F, Simpore J, Warimwe GM, et al. Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria. PLoS ONE. 2007;2:e978.
31. Cholera R, Brittain NJ, Gillrie MR, et al. Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci USA. 2008;105:991-996.
32. Thompson GR. Malaria and stress in relation to haemoglobins S and C. Br Med J. 1963;2:976-978.
33. Agarwal A, Guindo A, Cissoko Y, et al. Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Blood. 2000;96:2358-2363.
34. May J, Evans JA, Timmann C, et al. Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA. 2007;297:2220-2226.
35. Rihet P, Flori L, Tall F, Traore AS, Fumoux F. Hemoglobin C is associated with reduced Plasmodium falciparum parasitemia and low risk of mild malaria attack. Hum Mol Genet. 2004;13:1-6.
36. Guinet F, Diallo DA, Minta D, et al. A comparison of the incidence of severe malaria in Malian children with normal and C-trait hemoglobin profiles. Acta Trop. 1997;68:175-182.
37. Modiano D, Luoni G, Sirima BS, et al. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature. 2001;414:305-308.
38. Heller P, Best WR, Nelson RB, Becktel J. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med. 1979;300:1001-1005.
39. Robertson MG. Priapism and painless hematuria in hemoglobin C trait. JAMA. 1971;216:677.
40. Oksenhendler E, Bourbigot B, Desbazeille F, et al. Recurrent hematuria in 4 white patients with sickle cell trait. J Urol. 1984;132:1201-1203.
41. Sakarcan A, Stallworth J. Urea resolves gross hematuria in a 15 year old with hemoglobin C trait. Pediatr Nephrol. 2001;16:145-147.
42. Hingorani M, Bentley CR, Jackson H, et al. Retinopathy in haemoglobin C trait. Eye. 1996;10:338-342.
43. Nagpal KC, Asdourian GK, Patrianakos D, et al. Proliferative retinop-athy in sickle cell trait. Report of seven cases. Arch Intern Med. 1977;137:325-328.
44. Gibson BR, Peterson AC, Costabile RA. Priapism associated with hemoglobin C trait. J Urol. 2002;168:2122.
45. Birnbaum BF, Pinzone JJ. Sickle cell trait and priapism: a case report and review of the literature. Cases J. 2008;1:429.
46. Austin H, Key NS, Benson JM, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood. 2007;110:908-912.
47. Ashcroft MT, Miall WE, Milner PF. A comparison between the characteristics of Jamaican adults with normal hemoglobin and those with sickle cell trait. Am J Epidemiol. 1969;90:236-243.
48. Baill IC, Witter FR. Sickle trait and its association with birthweight and urinary tract infections in pregnancy. Int J Gynaecol Obstet. 1990;33: 19-21.
49. Miller JM Jr. Sickle cell trait in pregnancy. South Med J. 1983;76:962-963, 965.
50. Tuck SM, Studd JW, White JM. Pregnancy in women with sickle cell trait. Br J Obstet Gynaecol. 1983;90:108-111.
51. Wirthwein DP, Spotswood SD, Barnard JJ, Prahlow JA. Death due to microvascular occlusion in sickle-cell trait following physical exertion. J Forensic Sci. 2001;46:399-401.
52. Warren KE, Gidvani-Diaz V, Duval-Arnould B. Renal medullary carcinoma in an adolescent with sickle cell trait. Pediatrics. 1999;103:e22.
53. Tsaras G, Owusu-Ansah A, Boateng FO, Moateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review. Am J Med. 2009;122:507-512.
54. U.S. Department of Health and Human Services. National Center for Health Statistics 2005 National Immunization Surveys. Centers for Disease Control and Prevention, Vaccines and Immunizations. Available at: http://www.cdc.gov/ vaccines/stats-surv/nis/data/tables-2005.htm. Accessed August 31 2009.
55. Campbell M, Henthorn JS, Davies SC. Evaluation of cation-exchange HPLC compared with isoelectric focusing for neonatal hemoglobinop-athy screening. Clin Chem. 1999;45:969-975.